Website update in progress

Following the transformation of Polpharma Biologics (learn more), this site will focus on biosimilars development in Switzerland. In Poland, we operate now as Rezon Bio – a contract developer and manufacturer of biologics (CDMO). More at www.rezonbio.com.

Due to the demerger of Polpharma Biologics into two independent companies (detailed information can be found in the “Knowledge center” section), the website polpharmabiologics.com is currently being updated. For details on the CDMO business, please visit the Rezon Bio website

Go to Rezon Bio website

All hands on deck! We all fight with COVID-19

The current situation caused by COVID-19 concerns us all. We had decided to help because we care. That’s why we have donated personal protective equipment to the University Clinical Centre in Gdańsk. Among other items there were provided Tyvec coveralls, protective goggles and disposable gloves.

In the current situation of difficult access or lack of such equipment on the market, we hope that the donation will help doctors to fight the disease.

Related news

Other news related to this topic that may be of interest to you

nowybannerpb_Brazylia
Press release
Polpharma Biologics and Libbs Farmacêutica sign licensing agreement for a biosimilar for autoimmune diseases
Published: 10.12.2025
December 10, 2025 – Polpharma Biologics, a leading biopharmaceutical company specializing in the development...
Polpharma Biologics and Libbs Farmacêutica sign licensing agreement for a biosimilar for autoimmune diseases
PolpharmaBiologics-confirms-US-launch-Tyruko
Press release
Polpharma Biologics confirms U.S. launch of Tyruko® (natalizumab), the first and only biosimilar for Multiple Sclerosis
Published: 17.11.2025
November 17, 2025 – Polpharma Biologics, a biopharmaceutical company group focused on biosimilars development...
Polpharma Biologics confirms U.S. launch of Tyruko® (natalizumab), the first and only biosimilar for Multiple Sclerosis
banner_PB
Press release
Polpharma Biologics announces commercial launch of Europe’s first Pre-filled Syringe presentation of a ranibizumab biosimilar
Published: 21.10.2025
Zurich, Switzerland – October 21, 2025 – Polpharma Biologics today announced Ranivisio® PFS (ranibizumab...
Polpharma Biologics announces commercial launch of Europe’s first Pre-filled Syringe presentation of a ranibizumab biosimilar
rezon5
Press release
Polpharma Biologics is splitting its operations into two independent companies
Published: 29.09.2025
Polpharma Biologics is splitting its operations into two independent companies, each with a clear focus...
Polpharma Biologics is splitting its operations into two independent companies